{"name":"China National Biotec Group Company Limited","slug":"china-national-biotec-group-company-limited","ticker":"","exchange":"","domain":"cnbg.com.cn","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"oncology","drugs":[{"name":"COVAX","genericName":"COVAX","slug":"covax","indication":"Other","status":"marketed"},{"name":"COVAX+PPV23;COVAX+IIV4","genericName":"COVAX+PPV23;COVAX+IIV4","slug":"covax-ppv23-covax-iiv4","indication":"Other","status":"marketed"},{"name":"Inactivated Polio Vaccine","genericName":"Inactivated Polio Vaccine","slug":"inactivated-polio-vaccine","indication":"Other","status":"marketed"},{"name":"DTaP","genericName":"DTaP","slug":"dtap","indication":"Prevention of diphtheria, tetanus, and pertussis in infants and children","status":"marketed"},{"name":"HepA","genericName":"HepA","slug":"hepa","indication":"Other","status":"marketed"},{"name":"IIV4+PPV23","genericName":"IIV4+PPV23","slug":"iiv4-ppv23","indication":"Other","status":"marketed"},{"name":"Sabin-IPV and DTaP","genericName":"Sabin-IPV and DTaP","slug":"sabin-ipv-and-dtap","indication":"Other","status":"marketed"},{"name":"coadministration","genericName":"coadministration","slug":"coadministration","indication":"Other","status":"marketed"},{"name":"sIPV","genericName":"sIPV","slug":"sipv","indication":"Prevention of poliomyelitis (poliovirus types 1, 2, and 3)","status":"marketed"},{"name":"sIPV+DTaP+MMR","genericName":"sIPV+DTaP+MMR","slug":"sipv-dtap-mmr","indication":"Prevention of poliomyelitis","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"EV71 vaccine and influenza vaccine","genericName":"EV71 vaccine and influenza vaccine","slug":"ev71-vaccine-and-influenza-vaccine","indication":"Prevention of enterovirus 71 (EV71) infection and hand-foot-and-mouth disease","status":"marketed"},{"name":"COVAX only (1st and 2nd dose)","genericName":"COVAX only (1st and 2nd dose)","slug":"covax-only-1st-and-2nd-dose","indication":"COVID-19 prevention (SARS-CoV-2 infection)","status":"marketed"},{"name":"COVAX+IIV4; COVAX+PPV23","genericName":"COVAX+IIV4; COVAX+PPV23","slug":"covax-iiv4-covax-ppv23","indication":"COVID-19 prevention (COVAX component)","status":"marketed"},{"name":"IIV4 and PPV23","genericName":"IIV4 and PPV23","slug":"iiv4-and-ppv23","indication":"Prevention of seasonal influenza (IIV4)","status":"marketed"},{"name":"sIPV+DTaP+HepA","genericName":"sIPV+DTaP+HepA","slug":"sipv-dtap-hepa","indication":"Prevention of poliomyelitis","status":"marketed"}]}],"pipeline":[{"name":"COVAX","genericName":"COVAX","slug":"covax","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"COVAX+PPV23;COVAX+IIV4","genericName":"COVAX+PPV23;COVAX+IIV4","slug":"covax-ppv23-covax-iiv4","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"EV71 vaccine and influenza vaccine","genericName":"EV71 vaccine and influenza vaccine","slug":"ev71-vaccine-and-influenza-vaccine","phase":"marketed","mechanism":"This is a combination vaccine that stimulates the immune system to produce antibodies and cellular immunity against enterovirus 71 (EV71) and influenza viruses.","indications":["Prevention of enterovirus 71 (EV71) infection and hand-foot-and-mouth disease","Prevention of seasonal influenza"],"catalyst":""},{"name":"Inactivated Polio Vaccine","genericName":"Inactivated Polio Vaccine","slug":"inactivated-polio-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"COVAX only (1st and 2nd dose)","genericName":"COVAX only (1st and 2nd dose)","slug":"covax-only-1st-and-2nd-dose","phase":"marketed","mechanism":"COVAX is an inactivated COVID-19 vaccine that stimulates the immune system to produce antibodies and cellular immunity against SARS-CoV-2 by presenting inactivated viral particles.","indications":["COVID-19 prevention (SARS-CoV-2 infection)"],"catalyst":""},{"name":"COVAX+IIV4; COVAX+PPV23","genericName":"COVAX+IIV4; COVAX+PPV23","slug":"covax-iiv4-covax-ppv23","phase":"marketed","mechanism":"COVAX+IIV4 and COVAX+PPV23 are combination vaccines that provide immunization against COVID-19 (COVAX component) alongside seasonal influenza (IIV4) or pneumococcal disease (PPV23).","indications":["COVID-19 prevention (COVAX component)","Seasonal influenza prevention (IIV4 component)","Pneumococcal disease prevention (PPV23 component)"],"catalyst":""},{"name":"DTaP","genericName":"DTaP","slug":"dtap","phase":"marketed","mechanism":"DTaP is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria toxin, tetanus toxin, and pertussis antigens.","indications":["Prevention of diphtheria, tetanus, and pertussis in infants and children"],"catalyst":""},{"name":"HepA","genericName":"HepA","slug":"hepa","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"IIV4 and PPV23","genericName":"IIV4 and PPV23","slug":"iiv4-and-ppv23","phase":"marketed","mechanism":"IIV4 and PPV23 are inactivated influenza and pneumococcal vaccines that stimulate the immune system to produce antibodies against influenza virus strains and Streptococcus pneumoniae serotypes.","indications":["Prevention of seasonal influenza (IIV4)","Prevention of pneumococcal disease caused by Streptococcus pneumoniae serotypes in PPV23"],"catalyst":""},{"name":"IIV4+PPV23","genericName":"IIV4+PPV23","slug":"iiv4-ppv23","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Sabin-IPV and DTaP","genericName":"Sabin-IPV and DTaP","slug":"sabin-ipv-and-dtap","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"coadministration","genericName":"coadministration","slug":"coadministration","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"sIPV","genericName":"sIPV","slug":"sipv","phase":"marketed","mechanism":"sIPV is an inactivated polio vaccine that stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3.","indications":["Prevention of poliomyelitis (poliovirus types 1, 2, and 3)"],"catalyst":""},{"name":"sIPV+DTaP+HepA","genericName":"sIPV+DTaP+HepA","slug":"sipv-dtap-hepa","phase":"marketed","mechanism":"This combination vaccine provides immunization against poliomyelitis, diphtheria, tetanus, pertussis, and hepatitis A through inactivated viral and bacterial antigens.","indications":["Prevention of poliomyelitis","Prevention of diphtheria","Prevention of tetanus","Prevention of pertussis","Prevention of hepatitis A"],"catalyst":""},{"name":"sIPV+DTaP+MMR","genericName":"sIPV+DTaP+MMR","slug":"sipv-dtap-mmr","phase":"marketed","mechanism":"This combination vaccine provides immunization against poliomyelitis, diphtheria, tetanus, pertussis, measles, mumps, and rubella through inactivated viral and bacterial antigens.","indications":["Prevention of poliomyelitis","Prevention of diphtheria","Prevention of tetanus","Prevention of pertussis","Prevention of measles"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNRnRmY0JZb2pWRkxOTmRWT1liR0p4Smh0TzVhNDVFaHd0SGNoS0VVWVM2dW1fVkV3UzFJZUVNR3lUUDU0Q01fbW40XzlIQldVbkNmcVFLeWxDX1Rkb1dST1ljdTFZdDJOa3hOQnVPdDJqVlZaMFFmUnlTQ0RRVjFXcFhBVFRxQWMzWWxoam5YWjVSazg0SVZn?oc=5","date":"2026-01-14","type":"pipeline","source":"prosperousamerica.org","summary":"The China Dependence Big Pharma Doesn’t Want Washington to See - prosperousamerica.org","headline":"The China Dependence Big Pharma Doesn’t Want Washington to See","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQSVJRMUtJVWhzbmV0bkFYM0M0X0JUYUpBU2c2YzJPU1NkeW40Y2Q5elZnRXdZWjgyNzFxSTFSUS00ekpnY1puZEVZTkJjd3cxdTUtdjUxUmRBMWJoWnFoV29sM29tSHQxWnhFRExaVUR4Z0pqaEVPSWtyNE8tNWFjbDRHRFJHMU9EaFg5OVEwRE5JUlNDNTlUa2xR?oc=5","date":"2026-01-14","type":"pipeline","source":"BioSpace","summary":"Opinion: Trump Must Make Biotech Innovation a National Priority - BioSpace","headline":"Opinion: Trump Must Make Biotech Innovation a National Priority","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNLUZBMW1ycFFMUExyYkNjQVlqNXVWeWRMbUhSOGdEdFF3azZWN0xrQ0ZteHpzYWVTQ2lyYkVEOUwxUVRnVVF5Wlkybm5jSVFCWWU5NENRVGJkekdNcDZLNGNVeG9mQnlJS0JvM3drQ3QtUHJlMzMwczVzX0M1TTJKVVEwNVY?oc=5","date":"2025-09-12","type":"pipeline","source":"The New York Times","summary":"U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on China - The New York Times","headline":"U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOZGJJVFVwaHBHRG82bThjbEZnbTUwbDJXWXZtbW9QdHR1YXkzWUJIanlxcXNxcS1JeUxYVFFDdV95Z1AyQjAzdnVCNWtTbnhfS05SVlZVWW1MTXR0eU9Pc0JIa3lIeVBId2xIc08wUFJuRWFFcGF2U3BXNlI1aktYdU1VdGRURnk1ZXVkOUxrSXVDcDItQlB3eDlnN1NfclFTSFM3MkZWd3Q?oc=5","date":"2025-09-05","type":"pipeline","source":"C&EN","summary":"In the rise of Chinese biotech, some see opportunity. Others see a threat - C&EN","headline":"In the rise of Chinese biotech, some see opportunity. Others see a threat - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOanRRaXM2TkxObmtBTHZRdXJLcjNhcU5OS2JwVG1nQTNSVktpaG10akFpUFRmSTdUYUlPTDRObkVNeDA5cmItS0JTdmM4X1Z5Q1JoZ1ZISTNOV01BRmQwYjhZOWYzS3dSa2hHQzJVLXQwRjZ5R1N0ODNkdm43R3RlaGJR?oc=5","date":"2025-07-30","type":"pipeline","source":"Bain & Company","summary":"Empowering Biotech Innovation in Asia-Pacific - Bain & Company","headline":"Empowering Biotech Innovation in Asia-Pacific - Bain & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOa3cxV3lPSDdZS1NsQXFwdFpKTm1GMk1IVmJGbEpEUGh5M0tsNU5xMWtnR3hfd2dsdm81d3l5bi11M2sxTTl5dG0wemR2QVJmT1R4TjlUb3ZDcWdFdGhqM3hnMXItR3Y2RmJjNWFkSUR4a0NaMHNtbGNab2hGSkpFMHpzSjBCRjN0SlEtV2lIYVlTdWpGTlZtTk9JdjhIS3FrSmc?oc=5","date":"2025-06-18","type":"pipeline","source":"Life Science Leader","summary":"Structuring Cross Border China Biotech 'NewCo' Transactions - Life Science Leader","headline":"Structuring Cross Border China Biotech 'NewCo' Transactions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQZDJ6Zk54ckFkZElrSEVJc0hESVQyUDlValc2VjJiWnlwM2JyOTMtMk1mQ1BrNlBZTWVzaHNlQ2JyX2tuUnhCYXhwd2Q1WFVXdkxFQW9kZmNmbGpOSDZKczJDNzRDNFoxdkhSU1N6MEdEWjRsZWFDR1Y0Y2JxeXhiYTIyYzVRZ0xs?oc=5","date":"2025-04-24","type":"pipeline","source":"Mercator Institute for China Studies (MERICS)","summary":"Lab leader, market ascender: China's rise in biotechnology - Mercator Institute for China Studies (MERICS)","headline":"Lab leader, market ascender: China's rise in biotechnology - Mercator Institute for China Studies (MERICS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPN2N3Y1MxaHlzaWhHTkttQW44cGVhYm5VQ3JVLVp1Q1R6OHowUnlOcXY2UGJ2RlBESFdwUDltbGI1MFFBc3ZJUGNHSFpwQWxSSDlEQ25NbzAxMFF4V3NkU2pQdHRLZjdJZmFzdk1Ic01lU2UyQlMyNDNRYzdEdWhMcm5KaE43aFZUNER5NGNKYXhGUGVJaWtHeDBacF9hZXpzMEY2dWJUdmhoM01QNEZFNHBBLUVTTFR3Q0huVzlqSjM?oc=5","date":"2025-02-28","type":"deal","source":"Fierce Pharma","summary":"Trump's 'America First' investment policy raises uncertainty for US-China biotech dealmaking - Fierce Pharma","headline":"Trump's 'America First' investment policy raises uncertainty for US-China biotech dealmaking","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOdnlTNEh6YXNzQld1ek9QUUxNUF9aUXp0QjdxRm9ERmZZcEFUbDFQNjlqU1NPX0d4aDdmV1BGSHhfVDR3QWRETDFuNDBEWC0tajhIdG9IdzJNVUdrMnpIVVAzaFduZ1VlNHVHVmZKWkdKcGVabzlvckdYQUh2NzVIa19oaTFuTFR1TGZTS0dPM2lVRGVaS1VnWVV1UUFCSEVuMlI2QWxzOTF3Y0JuWURUM29qM0VBX3hpSTNqTVdvLUpYUThHYmtTTTVCNkhiUFBYUHJFQmhJWS1iT0ZnY3RRVA?oc=5","date":"2025-01-23","type":"pipeline","source":"Carnegie Endowment for International Peace","summary":"Biopharmaceuticals Rising: China’s Strategic Pivot to Southeast Asia Amid Great Power Tech Competition - Carnegie Endowment for International Peace","headline":"Biopharmaceuticals Rising: China’s Strategic Pivot to Southeast Asia Amid Great Power Tech Competition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQWS1SWGhZSlpkUndMVHJmZnA5clBub053NHpKR0YzRnQ3SGo5MmZ6RTNpWHc4VU5HYkNaQXpIeXl1RUFZREZBRktRVFZ4eF9GWWNhY1lWWjE0Q0pyU0JYRkE0TXM2VEtoeTZPT0h0VmdYQk9Zd2R6dlE4STdJYlF0SXVwZUFBU3AtZnc?oc=5","date":"2024-07-30","type":"pipeline","source":"Information Technology and Innovation Foundation (ITIF)","summary":"How Innovative Is China in Biotechnology? | Reports & Briefings | Jul 30, 2024 - Information Technology and Innovation Foundation (ITIF)","headline":"How Innovative Is China in Biotechnology? | Reports & Briefings | Jul 30, 2024 - Information Technology and Innovation F","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPMlBCOFhSQUFLVm5hYzBiSFpJcGdVMVAtVl9mbWZPVVF2Z0k2UFBoYURrSzk0VW9SdXYzMHBCRjFyel82c3BwZzZjYnpFRG5UMmFLeGdiQWtXS2tlc0NzY24yQkU1OTNSWE0teW5iM2ljanlQSVdsMnBQUGdvZlhlNWNrcVRHWkJLX1QzYXRtUVp4Z2VnX3Z5R3k3Z0FRN3lxTkcxdkUwQ0dFRFNhMjREWE9EYXJ1dnBzNXZtRnhONlRKS3M2?oc=5","date":"2024-04-19","type":"pipeline","source":"Reuters","summary":"Focus: China's drugmakers can't sell mRNA shots but haven't quit yet - Reuters","headline":"Focus: China's drugmakers can't sell mRNA shots but haven't quit yet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPUi1ieXJXVVlDYVZjaWJTM21FMC0wTlVBZTJ1S0tkaEtQYTZ5LXN6WEkxUU5mVnRUTjQwQnh3bF90c09ZV1VVYzlnenF4Q19VMzR4ZnIxM0JjQklPb045X09KQlJqTDF2VlFUQ1p3TUdnLTdyNTU3d3pxOTJxbkxtbDdZX1J1OHpBbmNneWs3UjB2dkk5UFJHNlA4MmptNVF1RW5Bd3ZzWQ?oc=5","date":"2023-05-15","type":"pipeline","source":"Bloomberg.com","summary":"China’s $220 Billion Biotech Initiative Is Struggling to Take Off - Bloomberg.com","headline":"China’s $220 Billion Biotech Initiative Is Struggling to Take Off","sentiment":"neutral"}],"patents":[],"drugCount":15,"phaseCounts":{"marketed":15},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}